dalteparin has been researched along with propiconazole in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Henderson, T; Lai, TF; Winlaw, W; Wu, J | 1 |
Malcolm, SJ | 1 |
Angelis, MD; Belcaro, G; Cesarone, MR; Ciucci, F; Lofoco, G; Nebbioso, M; Pascarella, A; Quercioli, P; Rapagnetta, L; Steigerwalt, RD | 1 |
Messari, J; Panitsa, G; Panitsas, A; Potamianou, A; Tesseromatis, C; Vovou, J | 1 |
4 other study(ies) available for dalteparin and propiconazole
Article | Year |
---|---|
Septic superior ophthalmic vein thrombosis: to coagulate or not to coagulate?
Topics: Anticoagulants; Bacteremia; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphylococcal Infections; Venous Thrombosis | 2002 |
Septic superior ophthalmic vein thrombosis: enoxaparin needs to be monitored.
Topics: Anticoagulants; Bacteremia; Drug Monitoring; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphylococcal Infections; Venous Thrombosis | 2002 |
Retinal and orbital venous occlusions treated with enoxaparin.
Topics: Adult; Aged; Aged, 80 and over; Drug Administration Schedule; Enoxaparin; Female; Humans; Injections, Subcutaneous; Male; Orbit; Retinal Vein Occlusion | 2008 |
Impact of hyperlipidaemia on the orbital bone cefotaxime levels in rats.
Topics: Animals; Anti-Bacterial Agents; Cefotaxime; Fatty Acids, Nonesterified; Heparin; Hyperlipidemias; Male; Nadroparin; Orbit; Rats; Rats, Wistar; Swimming; Tissue Distribution | 2010 |